Imidazoquinolineamines as adjuvants in HIV DNA vaccination

Details for Australian Patent Application No. 2003216852 (hide)

Owner Glaxo Group Limited PowderJect Research Limited

Inventors Ertl, Peter; Thomsen, Lindy; Van-Wely, Catherine; Braun, Ralph Patrick

Agent Spruson & Ferguson

Pub. Number AU-B-2003216852

PCT Number PCT/GB03/01213

PCT Pub. Number WO2003/080112

Priority 10/102,622 19.03.02 US; 60/366,058 19.03.02 US

Filing date 19 March 2003

Wipo publication date 8 October 2003

Acceptance publication date 11 September 2008

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 9/06 (2006.01) Medicinal preparations characterised by special physical form - Ointments

A61K 9/18 (2006.01) Medicinal preparations characterised by special physical form - Adsorbates

A61K 31/4745 (2006.01)

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/21 (2006.01) Medicinal preparations containing antigens or antibodies - Retroviridae, e.g. equine infectious anemia virus

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

C07K 14/16 (2006.01) Peptides having more than 20 amino acids

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 10/102,622 19.03.02 US; 60/366,058 19.03.02 US

13 November 2003 Application Open to Public Inspection

  Published as AU-B-2003216852

2 March 2006 Assignment before Grant

  Glaxo Group Limited; PowderMed Limited The application has been assigned to Glaxo Group Limited; PowderJect Research Limited

11 September 2008 Application Accepted

  Published as AU-B-2003216852

22 January 2009 Standard Patent Sealed

14 October 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003216853-IMPROVEMENTS RELATING TO INFORMATION DELIVERY

2003216851-Imidazoquinoline adjuvants for vaccines